## VTR: Ventas, Inc. - XLRE: Real Estate

### Executive Summary

No thesis match: MRS_20 -4.9% below STRENGTH zone (4.0-10.0%); PEG 1.74 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: momentum weakening (-4.7% MRS).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($74.47)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 10
- **Sentiment:** Bullish (Bullish: 3, Bearish: 0)

**1. Investment Management Corp of Ontario Boosts Holdings in Ventas, Inc. $VTR**
- Source: MarketBeat | 20251209T141545 | Somewhat-Bullish | Relevance: 100%
-  Investment Management Corp of Ontario significantly increased its stake in Ventas, Inc. by 1,019% in Q2, bringing its total holdings to 133,061 shares valued at approximately $8.4 million. This move is part of a broader trend of institutional investment, with firms collectively owning about 94% of Ventas stock. Despite recent insider selling and a high dividend payout ratio, analysts maintain a "Moderate Buy" rating for VTR, projecting an average target price of $78.40.

**2. Ventas declares quarterly dividend of $0.48 per share**
- Source: Investing.com | 20251210T220718 | Somewhat-Bullish | Relevance: 99%
- Ventas, Inc. (NYSE:VTR) has declared a quarterly dividend of $0.48 per common share, payable on January 15, 2026, to stockholders of record as of December 31, 2025. The real estate investment trust, specializing in properties for aging populations, has maintained dividend payments for 27 consecutive years with a current annual yield of 2.4%. This announcement follows recent positive third-quarter earnings, a successful $500 million senior notes offering, and a raised price target from Cantor Fitzgerald.

**3. Arrowstreet Capital Limited Partnership Reduces Holdings in Ventas, Inc. $VTR**
- Source: MarketBeat | 20251211T083126 | Neutral | Relevance: 99%
-  Arrowstreet Capital Limited Partnership has reduced its stake in Ventas, Inc. ($VTR) by 16.9% during the second quarter, now holding 120,779 shares valued at $7.63 million. Other institutional investors have also adjusted their positions, and company insiders, including the CEO and CFO, have sold a significant number of shares recently. Despite insider selling, analysts maintain a "Moderate Buy" consensus rating for Ventas, with an average target price of $78.40.

**4. Ventas declares quarterly dividend of $0.48 per share By Investing.com**
- Source: Investing.com Australia | 20251210T220901 | Somewhat-Bullish | Relevance: 99%
- Ventas, Inc. (NYSE:VTR) announced a quarterly dividend of $0.48 per common share, payable on January 15, 2026, to stockholders of record as of December 31, 2025. The real estate investment trust focuses on properties for aging populations and has consistently paid dividends for 27 years. This announcement follows strong third-quarter 2025 earnings and a successful senior notes offering.

**5. State Street Corp Buys 1,388,678 Shares of Ventas, Inc. $VTR**
- Source: MarketBeat | 20251211T114927 | Somewhat-Bullish | Relevance: 99%
-  State Street Corp increased its stake in Ventas, Inc. (NYSE:VTR) by 5.2% in the second quarter, buying an additional 1,388,678 shares to bring its total holdings to 27,998,629 shares valued at $1.78 billion. Other institutional investors also adjusted their positions in the real estate investment trust. The article also details Ventas's recent earnings, dividend announcement, analyst price targets, and insider trading activity.

### Analyst Activity

**Target Signal:** BULLISH (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-12-04 | Keybanc | $85 | $70 | +21% |
| 2025-11-25 | Wells Fargo | $88 | $80 | +10% |
| 2025-11-13 | Scotiabank | $80 | $74 | +8% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-12-04 | Keybanc | main | Overweight |
| 2025-11-25 | Wells Fargo | main | Overweight |
| 2025-11-13 | Scotiabank | main | Sector Perform |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 17 ($4.24M) |
| Sells | 14 ($23.22M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 62.7% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 7 / 2 |

**Top Holders:**
- Vanguard Group Inc: 15.7% (+2.5%)
- JPMORGAN CHASE & CO: 12.7% (+102.6%)
- Blackrock Inc.: 11.1% (+2.6%)
- State Street Corpora: 6.2% (+3.3%)
- FMR, LLC: 5.7% (+12.1%)

### Key Risks

1. Momentum deterioration: MRS_20 falling (-4.7% 5d) with bearish MACD, trend may be turning.
2. Heavy insider selling: $23M sold (14 transactions in 90 days).
3. Market regime shift could impact momentum names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +13%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 1.74 elevated, pricing in significant growth expectations. Analyst sentiment positive (3 raises, avg +13%). Insider selling cluster ($23.2M in 90 days), potential headwind. Institutional flow bullish (7 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $36.3B |
| Beta | 0.79 |
| 52W Range | $56.68 - $81.89 |
| Short Interest | 3.6% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 1.74 |
| Forward P/E | 136.8 |
| Current P/E | 286.2 |
| YoY Growth | 109.3% |
| EPS Direction | FALLING |

### Technicals

MRS_20 deteriorating from -0.2% to -4.9% (-4.7% in 5 days), indicating relative weakness vs NASDAQ. Below STRENGTH zone by 8.9pp (needs >4.0% for momentum thesis). Long-term uptrend intact (above SMA200 at 1.13x) but short-term weakness (below SMA20). MACD histogram bearish (-0.58), momentum weakening. RSI neutral at 46.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -4.87% (CS: 12) | Weak |
| RSI_14 | 46.0 | Neutral |
| MACD Histogram | -0.58 | Bearish |
| vs SMA20 | 0.972x | Below |
| vs SMA50 | 1.035x | Above |
| vs SMA200 | 1.127x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $77.27
- **Stop Loss:** $74.47 (3.6% risk)
- **Target:** $80.07 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 492
- **Position Value:** $38,016.84
- **Portfolio %:** 38.02%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | IGNITION (Zone D) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-11 (Est: $0.09)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q3 | $0.05 | $0.12 | +141.9% |
| 2025Q2 | $0.14 | $0.15 | +10.4% |
| 2025Q1 | $0.07 | $0.10 | +35.8% |
| 2024Q4 | $0.05 | $0.13 | +156.6% |

---
*RULE-based L3 | 2026-01-06 16:37 | MRS_20*